HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christoph Reiners Selected Research

Thyrotropin Alfa

4/2014Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.
8/2012Recombinant human thyrotropin to help confirm lack of evidence of radiation-induced differentiated thyroid cancer in young women seeking pregnancy.
8/2011Radioiodine for remnant ablation and therapy of metastatic disease.
7/2008Expanding indications for recombinant human TSH in thyroid cancer.
4/2006Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
3/2006A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal.
5/2005Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
3/2005rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christoph Reiners Research Topics

Disease

57Thyroid Neoplasms (Thyroid Cancer)
03/2023 - 07/2002
18Neoplasms (Cancer)
06/2023 - 06/2004
18Neoplasm Metastasis (Metastasis)
06/2023 - 03/2005
10Hypothyroidism
12/2021 - 08/2002
7Papillary Thyroid Cancer
06/2023 - 02/2004
5Carcinoma (Carcinomatosis)
08/2009 - 02/2004
4follicular Thyroid cancer
06/2023 - 01/2016
4Lymphatic Metastasis
06/2023 - 04/2009
4Body Weight (Weight, Body)
07/2011 - 08/2009
3Glioma (Gliomas)
02/2014 - 12/2009
3Follicular Adenocarcinoma
08/2009 - 02/2004
3Graves Disease (Basedow Disease)
05/2009 - 05/2004
2Breast Neoplasms (Breast Cancer)
01/2020 - 01/2020
2Osteoporosis
11/2015 - 01/2003
2medullary Thyroid cancer
04/2015 - 03/2011
2Goiter
04/2014 - 11/2012
2Fibrosis (Cirrhosis)
07/2013 - 09/2011
2Adrenocortical Carcinoma
07/2013 - 03/2012
2Hypersensitivity (Allergy)
05/2013 - 11/2011
2Glioblastoma (Glioblastoma Multiforme)
05/2011 - 12/2009
2Hyperthyroidism
05/2009 - 01/2002
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2022
1Thyroid Nodule (Nodule, Thyroid)
11/2020
1Colonic Neoplasms (Colon Cancer)
03/2018
1Carcinogenesis
03/2018
1Disease Progression
08/2015
1Hypoparathyroidism
01/2015
1Overweight
06/2014
1Fetal Death
08/2012
1Spontaneous Abortion (Miscarriage)
08/2012
1Meningioma (Meningiomas)
06/2012
1Thyroid Diseases (Thyroid Disease)
12/2011
1Fatigue
09/2011
1Pulmonary Fibrosis (Fibrosing Alveolitis)
04/2011
1Chronic Renal Insufficiency
03/2011
1Vomiting
05/2010
1Nausea
05/2010
1Sialadenitis
05/2010
1Autoimmune Diseases (Autoimmune Disease)
05/2009
1Adenocarcinoma
06/2008
1Melanoma (Melanoma, Malignant)
06/2008
1Adrenocortical Adenoma (Disease, Conn's)
06/2008
1Heart Failure
03/2006
1Migraine Disorders (Migraine)
03/2006
1Nodular Goiter
09/2005

Drug/Important Bio-Agent (IBA)

17IodineIBA
01/2022 - 10/2003
12Thyroid HormonesIBA
12/2021 - 10/2003
10Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
12/2021 - 10/2003
9ThyroglobulinFDA Link
01/2018 - 07/2002
8Thyrotropin AlfaFDA LinkGeneric
04/2014 - 03/2005
7RacivirIBA
06/2023 - 02/2004
7Thyroxine (Levothyroxine)FDA LinkGeneric
08/2012 - 12/2003
5Radioisotopes (Radionuclides)IBA
04/2015 - 12/2009
3NitratesIBA
01/2021 - 01/2015
3Iodine-131IBA
11/2020 - 12/2008
3iodophenyl metomidateIBA
07/2013 - 06/2008
2Drinking WaterIBA
03/2018 - 01/2015
2Tyrosine Kinase InhibitorsIBA
01/2018 - 08/2010
2Peptide Receptors (Peptide Receptor)IBA
04/2015 - 06/2012
2Capsules (Microcapsules)IBA
05/2011 - 12/2008
2Amino AcidsFDA Link
05/2011 - 12/2009
2Pentagastrin (Peptavlon)FDA Link
03/2011 - 08/2009
2Calcitonin (Calcitonin, Eel)FDA LinkGeneric
03/2011 - 08/2009
1Methylphenidate (Ritalin)FDA LinkGeneric
01/2022
1Dopamine (Intropin)FDA LinkGeneric
01/2022
1Environmental Pollutants (Pollutants, Environmental)IBA
03/2018
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018
1vandetanib (ZD6474)IBA
01/2018
1Indicators and Reagents (Reagents)IBA
12/2014
1ORALIT (ORS)IBA
06/2014
1Tyrosine (L-Tyrosine)FDA Link
02/2014
1Potassium Iodide (Pima)FDA Link
05/2013
1potassium perchlorateFDA Link
05/2013
1Octreotide (Sandostatin)FDA LinkGeneric
06/2012
1Oxygen (Dioxygen)IBA
09/2011
1Insulin (Novolin)FDA Link
07/2011
1IsofluraneFDA LinkGeneric
07/2011
1Phenylalanine (L-Phenylalanine)FDA Link
05/2011
1Bisbenzimidazole (Hoechst 33258)IBA
05/2011
1RadiopharmaceuticalsIBA
05/2011
1Propidium (Propidium Iodide)IBA
05/2011
1Trypan BlueFDA Link
05/2011
1ProcalcitoninIBA
03/2011
1Sorafenib (BAY 43-9006)FDA Link
08/2010
1Calcium Gluconate (CBG)IBA
08/2009
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
05/2009
1AutoantibodiesIBA
05/2009
1Hormones (Hormone)IBA
04/2006

Therapy/Procedure

47Therapeutics
03/2023 - 08/2002
9Thyroidectomy
01/2019 - 12/2003
8Radiotherapy
12/2021 - 01/2002
2Aftercare (After-Treatment)
01/2020 - 05/2011
2Drug Therapy (Chemotherapy)
09/2011 - 01/2005
2Lymph Node Excision (Lymph Node Dissection)
04/2006 - 12/2003
1Nuclear Power Plants
01/2015
1Nuclear Reactors
05/2013
1Off-Label Use
08/2011
1Intravenous Administration
12/2009
1Oral Administration
07/2005